Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis

Gulibahaer Ainiding, Ken Ichiro Yamashita, Takako Torii, Konosuke Furuta, Noriko Isobe, Takuya Matsushita, Katsuhisa Masaki, Shoji Matsumoto, Jun Ichi Kira

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

抄録

We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.

元の言語英語
ページ(範囲)108-112
ページ数5
ジャーナルJournal of Neuroimmunology
246
発行部数1-2
DOI
出版物ステータス出版済み - 5 15 2012

Fingerprint

Platelet Membrane Glycoprotein IIb
Myelitis
Blood Platelets
Platelet Glycoprotein GPIIb-IIIa Complex

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

これを引用

Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis. / Ainiding, Gulibahaer; Yamashita, Ken Ichiro; Torii, Takako; Furuta, Konosuke; Isobe, Noriko; Matsushita, Takuya; Masaki, Katsuhisa; Matsumoto, Shoji; Kira, Jun Ichi.

:: Journal of Neuroimmunology, 巻 246, 番号 1-2, 15.05.2012, p. 108-112.

研究成果: ジャーナルへの寄稿記事

@article{18056e587528455ebaac6dc534f39a55,
title = "Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis",
abstract = "We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.",
author = "Gulibahaer Ainiding and Yamashita, {Ken Ichiro} and Takako Torii and Konosuke Furuta and Noriko Isobe and Takuya Matsushita and Katsuhisa Masaki and Shoji Matsumoto and Kira, {Jun Ichi}",
year = "2012",
month = "5",
day = "15",
doi = "10.1016/j.jneuroim.2012.03.009",
language = "English",
volume = "246",
pages = "108--112",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis

AU - Ainiding, Gulibahaer

AU - Yamashita, Ken Ichiro

AU - Torii, Takako

AU - Furuta, Konosuke

AU - Isobe, Noriko

AU - Matsushita, Takuya

AU - Masaki, Katsuhisa

AU - Matsumoto, Shoji

AU - Kira, Jun Ichi

PY - 2012/5/15

Y1 - 2012/5/15

N2 - We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.

AB - We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.

UR - http://www.scopus.com/inward/record.url?scp=84860212572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860212572&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2012.03.009

DO - 10.1016/j.jneuroim.2012.03.009

M3 - Article

C2 - 22484027

AN - SCOPUS:84860212572

VL - 246

SP - 108

EP - 112

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -